Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 794

1.

Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model.

Yu T, Witten PE, Huysseune A, Buettner A, To TT, Winkler C.

Dis Model Mech. 2016 Feb 1;9(2):155-63. doi: 10.1242/dmm.019091. Epub 2015 Dec 24.

2.

Extracellular Iron is a Modulator of the Differentiation of Osteoclast Lineage Cells.

Xie W, Lorenz S, Dolder S, Hofstetter W.

Calcif Tissue Int. 2015 Nov 28. [Epub ahead of print]

PMID:
26615413
3.

[Frontier in bone biology].

Takeda S.

Nihon Rinsho. 2015 Oct;73(10):1628-33. Japanese.

PMID:
26529922
4.

Osteoclasts and Remodeling Based Bone Formation.

Kylmäoja E, Nakamura M, Tuukkanen J.

Curr Stem Cell Res Ther. 2015 Oct 19. [Epub ahead of print]

PMID:
26477623
5.

NanoUPLC-MS(E) proteomic analysis of osteoclastogenesis downregulation by IL-4.

Freire MS, Cantuária AP, Lima SM, Almeida JA, Murad AM, Franco OL, Rezende TM.

J Proteomics. 2016 Jan 10;131:8-16. doi: 10.1016/j.jprot.2015.10.004. Epub 2015 Oct 14.

PMID:
26459402
6.

Osteoclasts in the interface with electrospun hydroxyapatite.

Pasuri J, Holopainen J, Kokkonen H, Persson M, Kauppinen K, Lehenkari P, Santala E, Ritala M, Tuukkanen J.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:774-83. doi: 10.1016/j.colsurfb.2015.08.045. Epub 2015 Aug 28.

PMID:
26342323
7.

Targeted Proteomics-Driven Computational Modeling of Macrophage S1P Chemosensing.

Manes NP, Angermann BR, Koppenol-Raab M, An E, Sjoelund VH, Sun J, Ishii M, Germain RN, Meier-Schellersheim M, Nita-Lazar A.

Mol Cell Proteomics. 2015 Oct;14(10):2661-81. doi: 10.1074/mcp.M115.048918. Epub 2015 Jul 21.

PMID:
26199343
8.

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.

Greenblatt MB, Park KH, Oh H, Kim JM, Shin DY, Lee JM, Lee JW, Singh A, Lee KY, Hu D, Xiao C, Charles JF, Penninger JM, Lotinun S, Baron R, Ghosh S, Shim JH.

J Exp Med. 2015 Jul 27;212(8):1283-301. doi: 10.1084/jem.20150407. Epub 2015 Jul 20.

9.

Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.

Sophocleous A, Marino S, Logan JG, Mollat P, Ralston SH, Idris AI.

J Biol Chem. 2015 Sep 4;290(36):22049-60. doi: 10.1074/jbc.M115.649608. Epub 2015 Jul 20.

PMID:
26195631
10.

Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis.

Dyment NA, Breidenbach AP, Schwartz AG, Russell RP, Aschbacher-Smith L, Liu H, Hagiwara Y, Jiang R, Thomopoulos S, Butler DL, Rowe DW.

Dev Biol. 2015 Sep 1;405(1):96-107. doi: 10.1016/j.ydbio.2015.06.020. Epub 2015 Jun 30.

PMID:
26141957
11.

Bortezomib Inhibits Osteoclastogenesis and Porphyromonas gingivalis Lipopolysaccharide-induced Alveolar Bone Resorption.

Kim YG, Kang JH, Kim HJ, Kim HJ, Kim HH, Kim JY, Lee Y.

J Dent Res. 2015 Sep;94(9):1243-50. doi: 10.1177/0022034515592592. Epub 2015 Jun 30.

PMID:
26130255
12.

Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology.

Witwicka H, Hwang SY, Reyes-Gutierrez P, Jia H, Odgren PE, Donahue LR, Birnbaum MJ, Odgren PR.

PLoS One. 2015 Jun 4;10(6):e0128275. doi: 10.1371/journal.pone.0128275. eCollection 2015.

13.

[Frontiers in Live Bone Imaging Researches. Amazing function of osteocyte].

Nakashima T.

Clin Calcium. 2015 Jun;25(6):899-905. doi: CliCa1506899905. Review. Japanese.

PMID:
26017868
14.

[Frontiers in Live Bone Imaging Researches. In vivo imaging of osteoblasts].

Furuya M, Ishii M.

Clin Calcium. 2015 Jun;25(6):823-30. doi: CliCa1506823830. Review. Japanese.

PMID:
26017858
15.

[Frontiers in Live Bone Imaging Researches. Intravital imaging of osteoclast dynamics].

Kikuta J, Ishii M.

Clin Calcium. 2015 Jun;25(6):815-22. doi: CliCa1506815822. Review. Japanese.

PMID:
26017857
16.

In vivo monitoring of activated macrophages and neutrophils in response to ischemic osteonecrosis in a mouse model.

Phipps MC, Huang Y, Yamaguchi R, Kamiya N, Adapala NS, Tang L, Kim HK.

J Orthop Res. 2016 Feb;34(2):307-13. doi: 10.1002/jor.22952. Epub 2015 Jun 12.

PMID:
26016440
17.

TRAFD1 (FLN29) Interacts with Plekhm1 and Regulates Osteoclast Acidification and Resorption.

Witwicka H, Jia H, Kutikov A, Reyes-Gutierrez P, Li X, Odgren PR.

PLoS One. 2015 May 19;10(5):e0127537. doi: 10.1371/journal.pone.0127537. eCollection 2015.

18.

The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.

Yang Y, Blair HC, Shapiro IM, Wang B.

J Biol Chem. 2015 Jul 3;290(27):16918-28. doi: 10.1074/jbc.M115.663963. Epub 2015 May 15.

PMID:
25979341
19.

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.

Vinik Y, Shatz-Azoulay H, Vivanti A, Hever N, Levy Y, Karmona R, Brumfeld V, Baraghithy S, Attar-Lamdar M, Boura-Halfon S, Bab I, Zick Y.

Elife. 2015 May 8;4:e05914. doi: 10.7554/eLife.05914.

20.

Membrane nanotube formation in osteoclastogenesis.

Kukita T, Takahashi A, Zhang JQ, Kukita A.

Methods Mol Biol. 2015;1313:193-202. doi: 10.1007/978-1-4939-2703-6_14.

PMID:
25947666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk